Literature DB >> 8565409

Chronobiology and chronotherapy of asthma.

D J Pincus1, W R Beam, R J Martin.   

Abstract

There is no doubt that many pathophysiologic conditions change over a 24-hour period and thus therapy needs to be directed at these changes. In particular, asthma has been one of the better-studied disease processes in regard to circadian changes in pathophysiology. As we continue to learn more about circadian changes, better approaches to treating the disease with the same medications will emerge. It should be remembered that many asthmatics do not perceive their degree of bronchoconstriction. This was brought forth in Turner-Warwick's epidemiologic study in that less than one half of the asthmatic individuals who had problems with their asthma every night describe their asthma as being severe. The majority stated they either had mild or moderate asthma. Therefore, it is important that we use objective criteria such as peak flow meters in determining an individual patient's day-to-night changes in lung function. Then, any therapeutic intervention can be objectively determined at home with both the patient and physician gaining knowledge about the ongoing asthmatic process.

Entities:  

Mesh:

Year:  1995        PMID: 8565409

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  3 in total

1.  Procedures for numerical analysis of circadian rhythms.

Authors:  Roberto Refinetti; Germaine Corné Lissen; Franz Halberg
Journal:  Biol Rhythm Res       Date:  2007       Impact factor: 1.219

2.  Chronomodulated drug delivery system of salbutamol sulphate for the treatment of nocturnal asthma.

Authors:  J Qureshi; Mohd Amir; Alka Ahuja; Sanjula Baboota; J Ali
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

3.  Development of time controlled chronomodulated tablet with swelling and rupturable layers: Optimization of factors influencing lag-time and drug release.

Authors:  Mayur Desai; Rishad R Jivani; Laxman D Patel; Noordin P Jivani; Bhavin Sonagara
Journal:  Int J Pharm Investig       Date:  2012-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.